Clinical Trial Update: A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating SHR-8068 injections in combination with anti-tumor therapies for colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SHR-8068 injection (SHR-8068)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING